Cannvas Integrating Systems with Partner Namaste Technologies Inc. for Revenue Share Partnership
Cannvas.Me to Provide Seamless Referrals to NamasteMD
TORONTO, Dec. 4, 2018 /CNW/ – Cannvas MedTech Inc. (“Cannvas” or the “Company”) (CSE: MTEC) (Frankfurt: 3CM), a leading business technology company in the cannabis space, is pleased to report that integration of the revenue sharing partnership with Namaste Technologies Inc. (“Namaste”) (TSXV: N, FRA: M5BQ, OTCMKTS: NXTTF), a leading technology company operating the largest global cannabis e-commerce platform, is proceeding as planned. Cannvas and Namaste are deploying technologies to drive customer integration and value-added services between company platforms.
Namaste is the world’s largest and most comprehensive cannabis-focused e-commerce platform with a fully-integrated e-commerce network spanning across the globe offering everything from rolling papers to vaporizers. In Canada, Namaste has developed the country’s first telemedicine app, available on iPhone and Android devices, allowing patients to connect to doctors or nurse practitioners and have access to a wide range of high-quality cannabis products and services.
Cannvas.Me is a scalable and comprehensive solution for the global medical cannabis community offering interactive tools and physician-backed content to audiences wishing to learn about health care through cannabis. Its mission is to place users in the driver’s seat of their health care journey, arming them with unbiased information on whether medicinal or therapeutic use of cannabis can be beneficial to their lifestyle.
Cannvas.Me operates independently of any Licensed Producers or Clinic funding, working with its own Medical Advisory Board and Education Advisory Panel to provide a safe space for potential and active users to learn about cannabis with no pressure to consume or purchase.
About Namaste Technologies Inc.
Namaste Technologies is Your Everything Cannabis Store™. Namaste operates the largest global cannabis e-commerce platform with over 30 websites in 20+ countries under various brands. Namaste’s product offering through its subsidiaries includes vaporizers, glassware, accessories, CBD products, and the company will soon be selling medical cannabis in the Canadian market, subject to approval by Health Canada.
Namaste has developed and acquired innovative technology platforms including NamasteMD.com, an online patient portal, and in May 2018 the Company acquired a leading e-commerce AI and Machine Learning Company, Findify AB. Findify uses artificial intelligence algorithms to optimize and personalize a consumer’s on-site buying experience. Namaste is focused on leveraging its cutting-edge technology to enhance the user experience throughout its platforms. Namaste will continue to develop and acquire innovative technologies which will provide value to the Company and to its shareholders as well as to the broader cannabis market.
About Cannvas MedTech Inc.
Cannvas MedTech is a leading business technology company in the cannabis space. We design and build customer-centric solutions that enable our partners to harness the power of data to truly understand their customers, industry, and key business drivers.
No stock exchange or securities regulatory authority has reviewed or accepted responsibility for the adequacy or accuracy of this release.
Some of the statements contained in this release are forward-looking statements, such as estimates and statements that describe the Issuer’s future plans, objectives or goals, including words to the effect that the Issuer or management expects a stated condition or result to occur. Since forward-looking statements address future events and conditions, by their very nature, they involve inherent risks and uncertainties. For a description of the risks and uncertainties facing the Company and its business and affairs, readers should refer to the Company’s Management’s Discussion and Analysis and other disclosure filings with Canadian securities regulators, which are posted on www.sedar.com.
SOURCE Cannvas MedTech Inc.
For further information: www.cannvasmedtech.com; Media Inquiries, email@example.com